Shareholders might have noticed that Trulieve Cannabis Corp. (CSE:TRUL) filed its quarterly result this time last week. The early response was not positive, with shares down 8.9% to CA$9.25 in the past week. Revenues were in line with expectations, at US$288m, while statutory losses ballooned to US$0.11 per share. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there’s been a strong change in the company’s prospects, or if it’s business as usual. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year.
Following last week’s…
